Viziomed
↗Recife, Brazil
Viziomed is a Brazilian healthtech company founded in 2018 that specializes in artificial intelligence solutions for medical image analysis. The company provides an aggregated AI platform that brings together the best AI solutions globally for analysis of medical images including X-rays, mammography, and tomography. Viziomed operates as a B2B platform serving hospitals, clinics, and health operators, and has become the largest Artificial Intelligence platform in Latin America with a subsidiary in the United States. The company focuses on rapid and accurate early identification of major diseases like cancer through AI-driven diagnostic support.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Healthcare Technology / Biotechnology
Sub-Industry:AI Medical Imaging, Digital Health
SIZE & FINANCIALS
Employees:51-200
Revenue:Unknown
Founded:2018
Ownership:private
Status:operating
FUNDING
Stage:Post-Seed
Total Raised:$420K
Investors:Bold Capital, DOMO.VC, ACE Ventures, Bossa Invest
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A - Software/Platform company
Modalities:AI-powered medical imaging analysis
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Viziomed USA (subsidiary in United States)
Key Partnerships:Roche (contracted for AI-assisted diagnosis), AstraZeneca (contracted for AI-assisted diagnosis), MSD (contracted for AI-assisted diagnosis), Universities in Brazil, United States, and Australia (scientific research partnerships)
COMPETITION
Position:Leader
Competitors:PreviNEO (Brazil-based, AI for disease prevention), Heart Care (Brazil-based, AI for heart health monitoring), Viz.ai (global, AI for stroke care coordination), Lunit (global, AI medical imaging), Qure.ai (global, AI medical imaging)
LEADERSHIP
Key Executives:
Mávio Bishop - CEO
Filipe Guerra - Vice President / Co-founder
Jalingson Assis - CTO / Co-founder
Scientific Founders:Filipe Guerra, Jalingson Assis
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Viziomed. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.